Clinical trial
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing…
NCT00406393 · Medical College of Wisconsin, Other · Completed
Key facts
| NCT number | NCT00406393 |
|---|---|
| Title | Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) |
| Official title | A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402) |
| Lead sponsor | Medical College of Wisconsin, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Blood and Marrow Transplant Clinical Trials Network National Cancer Institute (NCI) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelocytic, Acute, Lymphocytic, Myeloid, Chronic, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Tacrolimus, Methotrexate, Sirolimus |
| Enrollment | 304 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2012 |
| Completion | Oct 1, 2015 |
| First posted | Dec 4, 2006 |
| Last update posted | Jan 4, 2023 |
| Countries | France, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: